Access Resources
1401 - 1425 of 7540 Results
Title
Year
- Divergent Cortical Tau Positron Emission Tomography Patterns Among Patients With Preclinical Alzheimer Disease2022RESTRICTEDTitle: Divergent Cortical Tau Positron Emission Tomography Patterns Among Patients With Preclinical Alzheimer DiseaseJournal Name: JAMA NeurologyPublisher: American Medical Association (AMA)Vol: 79Issue #: 6Start Page: 592End Page: 592Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1001/jamaneurol.2022.0676Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9016616Citation Count: 27
-
RESTRICTEDTitle: Droxidopa reduces postural sway in Parkinson disease patients with orthostatic hypotensionJournal Name: Parkinsonism & Related DisordersPublisher: Elsevier BVVol: 99Issue #:Start Page: 62End Page: 64Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.parkreldis.2022.05.002Citation Count: 2
-
RESTRICTEDTitle: Emerging roles of endoplasmic reticulum proteostasis in brain developmentJournal Name: Cells & DevelopmentPublisher: Elsevier BVVol: 170Issue #:Start Page: 203781End Page: 203781Publication Date:Open Access(OA) Status: RESTRICTEDLicense: publisher-specific-oaDOI - Digital Object Identifier: 10.1016/j.cdev.2022.203781Best OA location URL: https://doi.org/10.1016/j.cdev.2022.203781Citation Count: 4
- Exploration of whether socioeconomic factors affect the results of priority setting partnerships: updating the top 10 research priorities for the management of Parkinson’s in an international setting2022RESTRICTEDTitle: Exploration of whether socioeconomic factors affect the results of priority setting partnerships: updating the top 10 research priorities for the management of Parkinson’s in an international settingJournal Name: BMJ OpenPublisher: BMJVol: 12Issue #: 6Start Page: e049530End Page: e049530Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-byDOI - Digital Object Identifier: 10.1136/bmjopen-2021-049530Best OA location URL: https://bmjopen.bmj.com/content/bmjopen/12/6/e049530.full.pdfCitation Count: 2
- Gender differences in dopaminergic system dysfunction in de novo Parkinson's disease clinical subtypes2022RESTRICTEDTitle: Gender differences in dopaminergic system dysfunction in de novo Parkinson's disease clinical subtypesJournal Name: Neurobiology of DiseasePublisher: Elsevier BVVol: 167Issue #:Start Page: 105668End Page: 105668Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1016/j.nbd.2022.105668Best OA location URL: https://doi.org/10.1016/j.nbd.2022.105668Citation Count: 11
-
RESTRICTEDTitle: Glucose-lowering drugs, cognition, and dementia: The clinical evidenceJournal Name: Neuroscience & Biobehavioral ReviewsPublisher: Elsevier BVVol: 137Issue #:Start Page: 104654End Page: 104654Publication Date:Open Access(OA) Status: RESTRICTEDLicense: publisher-specific-oaDOI - Digital Object Identifier: 10.1016/j.neubiorev.2022.104654Best OA location URL: http://manuscript.elsevier.com/S0149763422001439/pdf/S0149763422001439.pdfCitation Count: 6
-
RESTRICTEDTitle: Group Exercise Classes Are Fun and MotivatingJournal Name: Brain & LifePublisher: Ovid Technologies (Wolters Kluwer Health)Vol: 18Issue #: 3Start Page: 10End Page: 11Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1097/01.nnn.0000834396.10260.d4Citation Count: 0
-
RESTRICTEDTitle: How Flavonoids Affect Parkinson's DiseaseJournal Name: Brain & LifePublisher: Ovid Technologies (Wolters Kluwer Health)Vol: 18Issue #: 3Start Page: 8End Page: 9Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1097/01.nnn.0000834392.64279.cfCitation Count: 0
-
RESTRICTEDTitle: Immune responses in the Parkinson's disease brainJournal Name: Neurobiology of DiseasePublisher: Elsevier BVVol: 168Issue #:Start Page: 105700End Page: 105700Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1016/j.nbd.2022.105700Best OA location URL: https://doi.org/10.1016/j.nbd.2022.105700Citation Count: 27
- Intracerebral administration of a modified antisense oligonucleotide targeting the dopamine system in a mouse model of Parkinson’s disease2022RESTRICTEDTitle: Intracerebral administration of a modified antisense oligonucleotide targeting the dopamine system in a mouse model of Parkinson’s diseaseJournal Name: STAR ProtocolsPublisher: Elsevier BVVol: 3Issue #: 2Start Page: 101445End Page: 101445Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1016/j.xpro.2022.101445Best OA location URL: https://doi.org/10.1016/j.xpro.2022.101445Citation Count: 0
-
RESTRICTEDTitle: Issue OverviewJournal Name: CONTINUUM: Lifelong Learning in NeurologyPublisher: Ovid Technologies (Wolters Kluwer Health)Vol: 28Issue #: 3Start Page:End Page:Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1212/01.con.0000840008.09408.75Citation Count: 0
- Modulation of miR-181 influences dopaminergic neuronal degeneration in a mouse model of Parkinson’s disease2022RESTRICTEDTitle: Modulation of miR-181 influences dopaminergic neuronal degeneration in a mouse model of Parkinson’s diseaseJournal Name: Molecular Therapy - Nucleic AcidsPublisher: Elsevier BVVol: 28Issue #:Start Page: 1End Page: 15Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1016/j.omtn.2022.02.007Best OA location URL: http://www.cell.com/article/S216225312200035X/pdfCitation Count: 9
-
RESTRICTEDTitle: Molecular mechanisms defining penetrance of LRRK2-associated Parkinson’s diseaseJournal Name: Medizinische GenetikPublisher: Walter de Gruyter GmbHVol: 34Issue #: 2Start Page: 103End Page: 116Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-byDOI - Digital Object Identifier: 10.1515/medgen-2022-2127Best OA location URL: https://www.degruyter.com/document/doi/10.1515/medgen-2022-2127/pdfCitation Count: 0
-
RESTRICTEDTitle: Pathogenic Impact of α-Synuclein Phosphorylation and Its Kinases in α-SynucleinopathiesJournal Name: International Journal of Molecular SciencesPublisher: MDPI AGVol: 23Issue #: 11Start Page: 6216End Page: 6216Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-byDOI - Digital Object Identifier: 10.3390/ijms23116216Best OA location URL: https://www.mdpi.com/1422-0067/23/11/6216/pdf?version=1654589185Citation Count: 24
-
RESTRICTEDTitle: Pathogenic LRRK2 regulates centrosome cohesion via Rab10/RILPL1-mediated CDK5RAP2 displacementJournal Name: iSciencePublisher: Elsevier BVVol: 25Issue #: 6Start Page: 104476End Page: 104476Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-byDOI - Digital Object Identifier: 10.1016/j.isci.2022.104476Best OA location URL: http://www.cell.com/article/S2589004222007477/pdfCitation Count: 13
- Perry Syndrome with Intrafamilial Heterogeneity in Presentation and Survival Including Acute Respiratory Failure: Case Series2022RESTRICTEDTitle: Perry Syndrome with Intrafamilial Heterogeneity in Presentation and Survival Including Acute Respiratory Failure: Case SeriesJournal Name: Movement Disorders Clinical PracticePublisher: WileyVol: 9Issue #: 6Start Page: 816End Page: 820Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-byDOI - Digital Object Identifier: 10.1002/mdc3.13473Best OA location URL: https://doi.org/10.1002/mdc3.13473Citation Count: 2
-
RESTRICTEDTitle: Pets May Be Good for Brain HealthJournal Name: Brain & LifePublisher: Ovid Technologies (Wolters Kluwer Health)Vol: 18Issue #: 3Start Page: 6End Page: 7Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1097/01.nnn.0000834384.40968.7eCitation Count: 0
- Pre‐existing humoral immune comebacks control the development of the severe form of coronavirus disease 2019 in Gaucher patients2022RESTRICTEDTitle: Pre‐existing humoral immune comebacks control the development of the severe form of coronavirus disease 2019 in Gaucher patientsJournal Name: Clinical and Translational DiscoveryPublisher: WileyVol: 2Issue #: 2Start Page:End Page:Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-byDOI - Digital Object Identifier: 10.1002/ctd2.96Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/ctd2.96Citation Count: 4
-
RESTRICTEDTitle: Proteome profiling of cerebrospinal fluid reveals biomarker candidates for Parkinson’s diseaseJournal Name: Cell Reports MedicinePublisher: Elsevier BVVol: 3Issue #: 6Start Page: 100661End Page: 100661Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-byDOI - Digital Object Identifier: 10.1016/j.xcrm.2022.100661Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9245058Citation Count: 45
- Safety, tolerability and pharmacokinetics of the oligomer modulator anle138b with exposure levels sufficient for therapeutic efficacy in a murine Parkinson model: A randomised, double-blind, placebo-controlled phase 1a trial2022RESTRICTEDTitle: Safety, tolerability and pharmacokinetics of the oligomer modulator anle138b with exposure levels sufficient for therapeutic efficacy in a murine Parkinson model: A randomised, double-blind, placebo-controlled phase 1a trialJournal Name: eBioMedicinePublisher: Elsevier BVVol: 80Issue #:Start Page: 104021End Page: 104021Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-byDOI - Digital Object Identifier: 10.1016/j.ebiom.2022.104021Best OA location URL: http://www.thelancet.com/article/S2352396422002055/pdfCitation Count: 26
-
RESTRICTED
- The Parkinson’s disease protein alpha-synuclein is a modulator of processing bodies and mRNA stability2022RESTRICTEDTitle: The Parkinson’s disease protein alpha-synuclein is a modulator of processing bodies and mRNA stabilityJournal Name: CellPublisher: Elsevier BVVol: 185Issue #: 12Start Page: 2035End Page: 2056.e33Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-by-nc-nd, cc-by-nc-nd, cc-by-nc-ndDOI - Digital Object Identifier: 10.1016/j.cell.2022.05.008Best OA location URL: http://www.cell.com/article/S009286742200592X/pdfCitation Count: 48
-
RESTRICTEDTitle: The Regulation of ImmunityJournal Name: The Journal of ImmunologyPublisher: The American Association of ImmunologistsVol: 208Issue #: 11Start Page: 2450End Page: 2455Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.4049/jimmunol.2290007Best OA location URL: https://journals.aai.org/jimmunol/article-pdf/208/11/2450/1501657/ji2290007.pdfCitation Count: 0
- The roles of connectivity and neuronal phenotype in determining the pattern of α-synuclein pathology in Parkinson's disease2022RESTRICTEDTitle: The roles of connectivity and neuronal phenotype in determining the pattern of α-synuclein pathology in Parkinson's diseaseJournal Name: Neurobiology of DiseasePublisher: Elsevier BVVol: 168Issue #:Start Page: 105687End Page: 105687Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-byDOI - Digital Object Identifier: 10.1016/j.nbd.2022.105687Best OA location URL: https://doi.org/10.1016/j.nbd.2022.105687Citation Count: 13
- Association of Motor and Nonmotor Symptoms With Health-Related Quality of Life in a Large Online Cohort of People With Parkinson Disease2022RESTRICTEDTitle: Association of Motor and Nonmotor Symptoms With Health-Related Quality of Life in a Large Online Cohort of People With Parkinson DiseaseJournal Name: NeurologyPublisher: Ovid Technologies (Wolters Kluwer Health)Vol: 98Issue #: 22Start Page:End Page:Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1212/wnl.0000000000200113Best OA location URL: https://n.neurology.org/content/neurology/98/22/e2194.full.pdfCitation Count: 17